“Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s293. doi:10.25251/skin.7.supp.293.